Related Experiment Video
Updated: May 27, 2025

Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization
Published on: July 27, 2021
BTS: scalable Bayesian Tissue Score for prioritizing GWAS variants and their functional contexts across omics data.
Pavel P Kuksa1, Matei Ionita1, Luke Carter1
1Penn Neurodegeneration Genomics Center, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
We developed Bayesian Tissue Score (BTS), a fast algorithm to map genetic variants to cell types and tissues using functional genomics data. BTS enhances the analysis of genome-wide association studies (GWAS) for complex diseases.
Area of Science:
- Genomics and Bioinformatics
- Computational Biology
- Statistical Genetics
Background:
- Genome-wide association studies (GWAS) are crucial for identifying genetic variants associated with diseases.
- Integrating GWAS with functional genomic (FG) data helps pinpoint causal variants and their cellular contexts.
- Existing methods struggle to scale with the growing volume of FG datasets for comprehensive analysis.
Purpose of the Study:
- To develop a scalable and efficient algorithm, Bayesian Tissue Score (BTS), for integrating large-scale FG annotations with GWAS summary statistics.
- To enable context-specific fine-mapping of causal variants by identifying relevant cell types and genomic features.
- To provide biological insights into the functional underpinnings of complex diseases.
Main Methods:
- Developed BTS, a novel Bayesian algorithm leveraging GWAS summary statistics and cell type-specific FG annotation tracks.
- Applied BTS to analyze diverse FG annotations, including enhancers, open chromatin, and histone marks.
- Evaluated BTS performance on GWAS data for immune (IBD, RA, SLE) and cardiovascular (CAD) diseases.
Main Results:
- BTS demonstrates over 100x greater efficiency in estimating functional annotation effects and variant fine-mapping compared to existing methods.
- The algorithm successfully identifies affected cell types and functional elements relevant to disease.
- BTS prioritizes known and novel functional annotations, cell types, genomic regions, and variants, offering significant biological insights.
Conclusions:
- BTS provides a highly efficient and scalable solution for integrating large-scale functional genomics data with GWAS.
- The algorithm facilitates context-specific variant fine-mapping and identification of disease-relevant cell types and genomic features.
- BTS offers valuable biological insights into the functional architecture of complex human diseases.
More Related Videos
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
Published on: August 21, 2016
04:41Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Genomics
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...